ArticleJournal of immunology research2026
An Optimized Feeder-Free Method for Isolation and Expansion of Functional ILC2s Isolated From Human Peripheral Blood.
Article in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Optimized Feeder-Free Method for Isolation and Expansion of Functional ILC2s Isolated From Human Peripheral Blood.Journal of immunology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Innate lymphoid cells (ILCs) are tissue-resident innate counterparts of T cells. Group 2 ILCs (ILC2s) produce cytokines such as IL-5 and IL-13 in response to alarmins, including IL-25 and IL-33 and play a key role in type 2 immunity. Lately, ILC2s have become a major focus across several research areas, including asthma, allergic lung inflammation, atopic dermatitis, and liver fibrosis. However, ILC2s are rare in human peripheral blood, making their isolation and expansion for functional studies challenging. Existing methods commonly rely on flow-cytometry-based cell sorting, which requires large sample volumes, expensive reagents, and considerable hands-on time. Moreover, in vitro expansion protocols often depend on feeder cell lines and activating alarmins. Here, we present a simple and efficient approach for isolating and expanding human ILC2s from peripheral blood, without the need for flow-cytometry-based cell sorting, feeder cells, or external alarmins. This method yields pure and viable ILC2s from both large and small blood volumes, enabling the use of limited or rare patient samples. Expanded ILC2s responded robustly to alarmin stimulation by proliferating and producing signature cytokines and retained functionality after cryopreservation and reculture. Together, this method provides a user-friendly and cost-effective alternative to current human ILC2 isolation and expansion protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.